Core team_Core team_Hangzhou Repugene Technology Co., Ltd.

Wang Tao, Director of Digital Health

He graduated from the Department of Computer Science at Peking University with a Ph.D. in Bioinformatics from Peking University and a postdoctoral fellowship at the University of California, San Diego.

Market Operations Consultant Mr. Wan Jiang

Market operations consultant
Mr. Wan Jiang
Senior Vice President of Beida Pharmaceutical;
Bachelor of Clinical Medicine, Capital Medical University;

Chief Clinical Medicine Consultant Professor Wang Yi

Chief clinical medical consultant
Professor Wang Yi
Double Ph.D. in Medicine and Molecular Biology, Arkansas School of Medicine, USA

Ms. Lou Shengqiong

Founder of the company, general manager of Rip Gene;
US MBA;
Vice President of Zhejiang Women Entrepreneurs Association;
Executive President of Hangzhou Women Entrepreneurs Association;
Senior investment manager;
Successfully established and managed the Great Wall International Restaurant Chain Group;
Invested in a number of domestic enterprises, covering biomedicine, information security and other fields, its investment in Beida Pharmaceuticals was successfully listed on the Shenzhen GEM in 2016.

Dr. Ding Liming

Founder of the company, senior consultant of Rip Gene;
NPC deputies, famous returnees scholars, national “Thousand Talents Program” experts, leading figures in Chinese pharmaceutical innovation, and also winners of the National Progress Award;
Fully leading Beida Pharmaceutical to complete the listing of “Kemena”, a molecular target drug for lung cancer with completely independent intellectual property rights, to break the monopoly of foreign products in this field;
Investment holding Xcovery, Kananji Medicine, Medical Kono Bio, Beida Anjin and other pharmaceutical companies.

Dr. Lin Rui, Director of Gene Sequencing

Doctor of Biomedical Sciences, University of Hawaii, USA
Postdoctoral fellow at the Scripps Research Institute
Has provided CRO services to many of the world's top pharmaceutical companies
Discover new tumor marker genes
Create a new high-sensitivity second-generation sequencing method

Dr. Li Nan, Director of Bioinformatics and Big Data

Doctor of Bioinformatics and Computational Biology, Chinese Academy of Sciences
Postdoctoral fellow at the University of California, San Diego
With many years of overseas R&D experience, he has published many important academic papers in Nature.
Expertise: High-throughput sequence analysis, bioinformatics process design and multiple machine learning methods

Chief Medical Consultant Dr. Mao Li

Chief medical consultant
Dr. Mao Li, Senior Vice President and Chief Medical Officer of Beida Pharmaceutical;
a tenured professor at the University of Texas Anderson Cancer Center;
Professor of Changjiang Scholars, School of Medicine, Shanghai Jiaotong University; expert of the National “Thousand Talents Program”;